Removal of UK-donor deferral for variant Creutzfeldt–Jakob disease: A large donation gain in Australia
In Australia, from December 2000 until discontinuation in July 2022, Lifeblood indefinitely deferred people who spent more than 6 months in the United Kingdom during the variant Creutzfeldt–Jakob disease (vCJD) risk period, 1980–1996 to mitigate the potential blood safety risk.
Find out more